Queen Elizabeth II Health Sciences Centre (Site 1731)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Cervical cancer

Closed trials

• Completed

  Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

  NCT03635567· Phase 3· Merck Sharp & Dohme LLC· Source